Any 0 3 0 3 O
infant 4 10 4 10 O
who 11 14 11 14 O
, 14 15 14 15 O
in 16 18 16 18 O
the 19 22 19 22 O
opinion 23 30 23 30 O
of 31 33 31 33 O
his 34 37 34 37 O
or 38 40 38 40 O
her 41 44 41 44 O
pediatrician 45 57 45 57 O
or 58 60 58 60 O
the 61 64 61 64 O
investigators 65 78 65 78 O
, 78 79 78 79 O
has 80 83 80 83 O
a 84 85 84 85 O
major 86 91 86 91 O
medical 92 99 92 99 O
problem 100 107 100 107 O
( 108 109 108 109 O
such 109 113 109 113 O
as 114 116 114 116 O
cardiac 117 124 117 124 B-treatment
pathology 125 134 125 134 I-treatment
or 135 137 135 137 O
airway 138 144 138 144 B-chronic_disease
obstruction 145 156 145 156 I-chronic_disease
) 156 157 156 157 O
that 158 162 158 162 O
makes 163 168 163 168 O
participation 169 182 169 182 O
in 183 185 183 185 O
the 186 189 186 189 O
study 190 195 190 195 O
difficult 196 205 196 205 O

Infant 0 6 206 212 O
with 7 11 213 217 O
one 12 15 218 221 O
or 16 18 222 224 O
more 19 23 225 229 O
superficial 24 35 230 241 O
hemangiomas 36 47 242 253 B-cancer
in 48 50 254 256 O
the 51 54 257 260 O
preproliferative 55 71 261 277 O
phase 72 77 278 283 O
or 78 80 284 286 O
very 81 85 287 291 O
early 86 91 292 297 O
proliferative 92 105 298 311 O
growth 106 112 312 318 O
phase 113 118 319 324 O

Infants 0 7 325 332 O
already 8 15 333 340 O
on 16 18 341 343 O
other 19 24 344 349 O
treatment 25 34 350 359 B-treatment
prior 35 40 360 365 O
to 41 43 366 368 O
PDL 44 47 369 372 O
or 48 50 373 375 O
timolol 51 58 376 383 B-treatment
treatments 59 69 384 394 I-treatment
( 70 71 395 396 O
including 71 80 396 405 O
topical 81 88 406 413 B-treatment
, 88 89 413 414 O
systemic 90 98 415 423 B-treatment
steroids 99 107 424 432 I-treatment
or 108 110 433 435 O
other 111 116 436 441 B-treatment
agents 117 123 442 448 I-treatment
) 123 124 448 449 O

Infants 0 7 450 457 O
with 8 12 458 462 O
hemangiomas 13 24 463 474 B-cancer
that 25 29 475 479 O
threaten 30 38 480 488 O
vital 39 44 489 494 O
functions 45 54 495 504 O
( 55 56 505 506 O
e.g. 56 60 506 510 O
obstructing 61 72 511 522 O
the 73 76 523 526 O
airway 77 83 527 533 O
or 84 86 534 536 O
impairing 87 96 537 546 O
hearing 97 104 547 554 O
or 105 107 555 557 O
vision 108 114 558 564 O
) 114 115 564 565 O

More 0 4 566 570 O
pronounced 5 15 571 581 O
appearance 16 26 582 592 O
within 27 33 593 599 O
1 34 35 600 601 B-upper_bound
month 36 41 602 607 I-upper_bound
of 42 44 608 610 O
birth 45 50 611 616 O

Patients 0 8 617 625 O
with 9 13 626 630 O
asthma 14 20 631 637 B-chronic_disease
or 21 23 638 640 O
a 24 25 641 642 O
history 26 33 643 650 O
of 34 36 651 653 O
asthma 37 43 654 660 O
, 43 44 660 661 O
chronic 45 52 662 669 B-chronic_disease
obstructive 53 64 670 681 I-chronic_disease
pulmonary 65 74 682 691 I-chronic_disease
disease 75 82 692 699 I-chronic_disease
or 83 85 700 702 O
cardiovascular 86 100 703 717 B-chronic_disease
disease 101 108 718 725 I-chronic_disease
, 108 109 725 726 O
including 110 119 727 736 O
sinus 120 125 737 742 B-chronic_disease
bradycardia 126 137 743 754 I-chronic_disease
, 137 138 754 755 O
second 139 145 756 762 B-chronic_disease
or 146 148 763 765 I-chronic_disease
third 149 154 766 771 I-chronic_disease
degree 155 161 772 778 I-chronic_disease
atrioventricular 162 178 779 795 I-chronic_disease
block 179 184 796 801 I-chronic_disease
, 184 185 801 802 O
overt 186 191 803 808 B-chronic_disease
cardiac 192 199 809 816 I-chronic_disease
failure 200 207 817 824 I-chronic_disease
, 207 208 824 825 O
and 209 212 826 829 O
cardiogenic 213 224 830 841 B-chronic_disease
shock 225 230 842 847 I-chronic_disease
; 230 231 847 848 O
hypersensitivity 232 248 849 865 O
to 249 251 866 868 O
any 252 255 869 872 O
component 256 265 873 882 O
of 266 268 883 885 O
timolol 269 276 886 893 B-allergy_name
; 276 277 893 894 O
and 278 281 895 898 O
in 282 284 899 901 O
those 285 290 902 907 O
patients 291 299 908 916 O
receiving 300 309 917 926 O
systemic 310 318 927 935 O
administration 319 333 936 950 O
of 334 336 951 953 O
beta 337 341 954 958 B-allergy_name
- 341 342 958 959 I-allergy_name
blockers 342 350 959 967 I-allergy_name
or 351 353 968 970 O
ace 354 357 971 974 B-allergy_name
inhibitors 358 368 975 985 I-allergy_name

Scarring 0 8 986 994 O
or 9 11 995 997 O
infection 12 21 998 1007 B-chronic_disease
of 22 24 1008 1010 O
the 25 28 1011 1014 O
area 29 33 1015 1019 O
to 34 36 1020 1022 O
be 37 39 1023 1025 O
treated 40 47 1026 1033 O

Willingness 0 11 1034 1045 O
of 12 14 1046 1048 O
parent 15 21 1049 1055 O
/ 21 22 1055 1056 O
guardian 22 30 1056 1064 O
to 31 33 1065 1067 O
follow 34 40 1068 1074 O
the 41 44 1075 1078 O
treatment 45 54 1079 1088 B-treatment
schedule 55 63 1089 1097 O
and 64 67 1098 1101 O
post 68 72 1102 1106 O
treatment 73 82 1107 1116 O
care 83 87 1117 1121 O
requirements 88 100 1122 1134 O

Willingness 0 11 1135 1146 O
of 12 14 1147 1149 O
parent 15 21 1150 1156 O
/ 21 22 1156 1157 O
guardian 22 30 1157 1165 O
to 31 33 1166 1168 O
not 34 37 1169 1172 O
use 38 41 1173 1176 O
topical 42 49 1177 1184 B-treatment
or 50 52 1185 1187 I-treatment
systemic 53 61 1188 1196 I-treatment
( 62 63 1197 1198 I-treatment
oral 63 67 1198 1202 I-treatment
) 67 68 1202 1203 I-treatment
TREATMENT 69 78 1204 1213 I-treatment
medications 79 90 1214 1225 I-treatment
of 91 93 1226 1228 O
the 94 97 1229 1232 O
hemangioma 98 108 1233 1243 B-chronic_disease
other 109 114 1244 1249 O
than 115 119 1250 1254 O
those 120 125 1255 1260 O
prescribed 126 136 1261 1271 O
by 137 139 1272 1274 O
the 140 143 1275 1278 O
investigators 144 157 1279 1292 O
during 158 164 1293 1299 O
the 165 168 1300 1303 O
study 169 174 1304 1309 O
period 175 181 1310 1316 O

Willingness 0 11 1317 1328 O
of 12 14 1329 1331 O
parent 15 21 1332 1338 O
/ 21 22 1338 1339 O
guardian 22 30 1339 1347 O
to 31 33 1348 1350 O
receive 34 41 1351 1358 O
EXPERIMENTAL 42 54 1359 1371 O
treatment 55 64 1372 1381 B-treatment

aged 0 4 1382 1386 B-age
less 5 9 1387 1391 O
than 10 14 1392 1396 O
3 15 16 1397 1398 B-upper_bound
months 17 23 1399 1405 I-upper_bound

female 0 6 1406 1412 B-gender

male 0 4 1413 1417 B-gender

who 0 3 1418 1421 O
are 4 7 1422 1425 O
immunocompromised 8 25 1426 1443 B-chronic_disease

whose 0 5 1444 1449 O
parent 6 12 1450 1456 O
/ 12 13 1456 1457 O
guardian 13 21 1457 1465 O
is 22 24 1466 1468 O
unable 25 31 1469 1475 O
to 32 34 1476 1478 O
comply 35 41 1479 1485 O
with 42 46 1486 1490 O
treatment 47 56 1491 1500 B-treatment
, 56 57 1500 1501 O
home 58 62 1502 1506 O
care 63 67 1507 1511 O
or 68 70 1512 1514 O
follow 71 77 1515 1521 O
- 77 78 1521 1522 O
up 78 80 1522 1524 O
visits 81 87 1525 1531 O

